Search Results - john+roback

5 Results Sort By:
Improved Clinical Diagnostic Method for SARS-CoV-2 Infection
Application A more reliable and accurate method for diagnosing SARS-CoV-2 infection based on the biochemical interactions between the spike trimer and ACE-2 protein. Key Benefits A fast, affordable, and easy-to-use SARS-Cov-2 diagnostic test for use in clinical settings. Market Summary SARS-CoV-2 has evolved significantly since the onset of...
Published: 9/26/2024   |   Inventor(s): John Roback, Andrew Neish, Narayanaiah Cheedarla, Hans Verkerke, Huixia Wu, William Osick, Kaleb Mclendon, Sindhu Potlapalli
Keywords(s): COVID19, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Research Tools, TechPub Algolia > Diagnostics
Serological Test for SARS-CoV-2
­ Application Clinical assay for detecting SARS-CoV-2 neutralizing antibodies. Key Benefits Highly specific and sensitive. Fewer false positives than commercially available tests. Market Summary SARS-CoV-2 is currently causing a devastating pandemic and there is a pressing need to understand the dynamics, specificity, and neutralizing...
Published: 7/30/2024   |   Inventor(s): Rafi Ahmed, Mehul Suthar, John Roback, Jens Wrammert, Robert Kauffman
Keywords(s): Assay, COVID19, Microbiology/Infectious Diseases, Vaccine
Category(s): TechPub Algolia > Diagnostics, TechPub Algolia > Drug Discovery, TechPub Algolia > Micro and Nanotechnology
Algorithm and Software Application for the Diagnosis of Adverse Reactions to Blood Transfusion
Application Web-based and mobile application based on the National Healthcare Safety Network’s Biovigilance Component Hemovigilance Module Surveillance Protocol to aid in the identification of adverse reactions to transfusions easily and accurately. Key Benefits Provides a quick, easy, and accurate method to identify transfusion reactions...
Published: 7/30/2024   |   Inventor(s): John Roback, Geoffrey Smith
Keywords(s): Hematology/Blood Products
Category(s): TechPub Algolia > Software
Biologic Therapeutic for Graft-versus-Host Disease (GvHD)
Application Biotherapeutic activation of toll-like receptor 5 (TLR5) to treat graft-versus-host disease (GvHD). Key Benefits Administration of flagellin reduces both acute and chronic GvHD. Contrary to immunosuppressive drugs, flagellin enhances immunity and protects patients from opportunistic infections. Market Summary Transplant recipients...
Published: 9/26/2024   |   Inventor(s): Mohammad Hossain, Andrew Gewirtz, John Roback, Edmund K. Waller
Keywords(s): Biologic, Immunology/Inflammation, Microbiology/Infectious Diseases
Category(s): TechPub Algolia > Drug Discovery, TechPub Algolia > Therapeutics
Evaluation of Red Blood Cells (RBC) to Predict Post-Transfusion Survival
Application Technique to evaluate red blood cell units (RBC) and predict their post-transfusion survival. Key Benefits No existing techniques to predict post-transfusion survival of RBC units. Provides a quality control technique to predict post-transfusion survival of RBC units prior to transfusion. Market Summary Millions of patients are...
Published: 7/30/2024   |   Inventor(s): James Zimring, John Roback, Larry Dumont
Keywords(s): Hematology/Blood Products
Category(s): TechPub Algolia > Diagnostics